✓
No active regulatory warnings
Sources: FDA MedWatch, EMA EudraVigilance, WHO VigiBase, WADA Prohibited List · 2026-05-29
1 Identity
Saw Palmetto + Biotin
Serenoa repens + D-Biotin (hair formula)
Generally SafeEvidence: LimitedOtherSaw palmetto + biotin is a common combination product marketed for hair loss, combining saw palmetto (5α-reductase inhibitor, traditionally used for BPH) with biotin (B vitamin involved in keratin synthesis) [1]. The rationale: saw palmetto's anti-androgenic activity + biotin's keratin support may address both hormonal and nutritional aspects of hair thinning. Evidence is limited to small studies of combination products; no RCTs have isolated the specific contribution of this particular pairing [1].
2 Risk self-assessment
Not applicable [1].
Select factors above to see your risk level
4 Lab interpreter
See overview
Your level:
Enter a value above
⚕ For healthcare professionals. Does not replace clinical judgment.
5 Quick facts
CategoryOther
Safety levelGenerally Safe
EvidenceLimited
RDATypical 320 mg SP + 2,500–5,000 mcg biotin
Upper limit (UL)No UL
Scientific nameSerenoa repens + D-Biotin (hair formula)
Category entrySee overview for key points [1]
6 Dosage by population
Adults Moderate
See product label
Elderly Moderate
See product label
Consider reduced renal/hepatic clearance. Start at lower end of range.
Athletes Limited
Standard dose
Obesity Limited
Standard dose
Fat-soluble compounds may require dose adjustment in obesity.
Renal Limited
Consult specialist
Dose adjustment may be needed in renal impairment.
Vegan Moderate
Standard dose
Per product label [1].
7 Form comparison
| Form | Bioavailability | Vegan | Cost/day |
|---|---|---|---|
| ['Various commercial forms', 'standard', 'See product labels [1].'] | Standard | Check label |
8 Clinical evidence
Strong evidence
See overview [1]. HIGH
Moderate evidence
See overview [1]. MODERATE
Insufficient evidence
See overview [1]. LOW
9 Safety
🚩 Red flags — when to stop and refer
● See overview for safety concerns [1]
Pregnancy
Consult healthcare provider [1].
Pediatric
Per product guidance [1].
10 Toxicity and overdose
11 Drug interactions
12 Supplement interactions
13 Laboratory monitoring
14 Deficiency and prevalence
Risk factors
• Not applicable [1].
15 Frequently asked questions
See overview ▼
Saw palmetto + biotin is a popular hair-loss combination with plausible but unproven synergy. Saw palmetto's 5α-reductase inhibition is proven for BPH, not hair loss (limited hair data). Biotin deficiency causes hair loss but supplementation only helps if deficient (rare in healthy adults). The combination hasn't been studied as a specific pair [1].
16 Regulatory status
United States (FDA): Dietary supplement/food [1].
17 References
[1]See individual ingredient entries for detailed references. REVIEW
18 Related articles
📰 Article placeholder — auto-populated via news.gmj.ge
📰 Article placeholder — auto-populated via news.gmj.ge
📰 Article placeholder — auto-populated via news.gmj.ge
📰 Article placeholder — auto-populated via news.gmj.ge
Auto-updated from GMJ Newsroom. Articles tagged "Saw Palmetto + Biotin" appear here.
19 Cite this page
Vancouver
Pkhakadze G. Saw Palmetto + Biotin — safety profile [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 May 30]. Available from: https://supplement.ge/ingredients/saw-palmetto-biotin/
APA 7th
Pkhakadze, G. (2026). Saw Palmetto + Biotin — Safety profile. Public Health Institute of Georgia. https://supplement.ge/ingredients/saw-palmetto-biotin/
CC BY 4.0
🛡 SupplementIndex receives no funding from supplement manufacturers. All content independently authored by PHIG.
GP
Reviewed by Prof. G. Pkhakadze, MD, MPH, PhD
Editor-in-Chief, Georgian Medical Journal · Chair, PHIG
Last reviewed: May 2026 · Next: November 2026
This entry is provided for educational and public health purposes under CC BY 4.0. Consult your healthcare provider before starting any supplement. For corrections: info@accreditation.ge.
Publisher: PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Publisher: PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD